BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Patent

IQVIA and Veeva Forge Global Clinical and Commercial Partnerships, Resolve Legal Disputes

IQVIA and Veeva Systems announced global clinical and commercial partnerships and the complete resolution of all pending legal disputes. Und...

August 19, 2025 | News

Genprex Secures Key U.S. and European Patents for REQORSA® Gene Therapy in Combination with Checkpoint Inhibitors

Genprex, Inc., a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, announced t...

August 19, 2025 | News

KBP Biosciences Welcomes Court’s Decision to Maintain Injunction Pending Arbitration with Novo Nordisk

KBP Biosciences Pte. Ltd. issued a statement addressing a further decision by the Singapore International Commercial Court (the "Court") to maintain the te...

August 13, 2025 | Regulatory

Hoth Therapeutics Secures Japan Patent for HT-KIT Splice-Switching Platform Targeting Mast Cell Disorders

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company developing innovative therapies, today announced that they have obtained...

June 13, 2025 | News

SK Bioscience Wins Supreme Court Patent Battle Against Pfizer Over Pneumococcal Vaccine

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that it the Supreme C...

May 22, 2025 | News

Hyundai ADM Bio Withdraws IND for Penetrium™/Docetaxel and Pivots to Immunotherapy Combinations

Hyundai ADM Bio announced the voluntary withdrawal of its Investigational New Drug (IND) application for Phase 1 clinical trial evaluating Pene...

May 14, 2025 | News

SK Bioscience Wins Patent Case Against Moderna Clearing Path for Global mRNA Vaccine Development

SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, today announced that it has won...

April 24, 2025 | News

Patent Wars and Patient Lives: Inside Roche vs Natco Over Risdiplam

In a courtroom packed with legal heavyweights, global pharmaceutical giant F. Hoffmann-La Roche AG faced off against Indian generic manufac...

April 14, 2025 | Analysis

Darnatein Secures First International Patent in China for AI-Engineered Osteoarthritis Drug Technology

Darnatein, a wholly-owned subsidiary of OSR Holdings, Inc. (NASDAQ: OSRH), today announces that it has successfully secured an additional international pat...

April 10, 2025 | News

Bayer Seeks U.S. Supreme Court Intervention in Missouri Roundup™ Case Amid Nationwide Labeling Disputes

Bayer – through its indirect subsidiary Monsanto – filed its petition for a writ of certiorari with the U.S. Supreme Court in the&nbs...

April 07, 2025 | News

Exicure Secures Australian Patent for Dual-Target Cancer Therapy Approach

Exicure, Inc. announced that the Australian Patent Office has issued Patent No. 2018388302, titled "GPCR Heteromer Inhibitors and Uses Thereof." ...

March 14, 2025 | News

BP Biosciences Responds to Singapore Court Injunction in Novo Nordisk Dispute

BP Biosciences Pte. Ltd. issued a statement addressing a recent decision by the Singapore International Commercial Court ("SICC"), which granted an i...

February 28, 2025 | News

QIAGEN Secures Major Legal Victory Defending QuantiFERON Innovation Against SD Biosensor

QIAGEN N.V. announced that the German Federal Patent Court (Bundespatentgericht) has ruled in its favor in a patent dispute against SD Biosensor, reaffirmi...

February 05, 2025 | News

RenovoRx Strengthens IP Portfolio with 18 Issued and 13 Pending Patents as it Advances TAMP™ Therapy and RenovoCath Commercialization

RenovoRx Holds a Strong IP Portfolio with 18 Issued Patents and 13 Pending Patents as it Moves Forward with Commercialization and Clinical Trial Plan...

January 02, 2025 | News

Stay Connected